Group 1-winning jockey Tyler Schiller is hoping to receive medical clearance this week to resume riding after a race-day ...

The Centers for Medicare and Medicaid Services will be implementing prior authorization requirements for certain traditional ...

Biocon Biologics Receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars Bengaluru, Karnataka, India, July 7, 2025  Biocon Biologics Ltd (BBL), a fully integrated global biosimilars ...

A 74-year-old man sustained a T12 compression fracture after being rear-ended by an unlicensed driver in Henrico County.

In people with vertebral fragility fractures, a tailored exercise adherence intervention integrated with physiotherapy ...

Indian biosimilars company Biocon Biologics, a subsidiary of Biocon Ltd (BSE: 532520), today announced that the UK’s ...

Biocon Biologics receives marketing authorizations for Vevzuo and Evfraxy biosimilars for bone-related diseases in the UK.

New Delhi: Biocon Ltd on Monday said its arm Biocon Biologics Ltd has received marketing authorisations from the Medicines ...

Biocon Biologics receives UK MHRA approval for Vevzuo & Evfraxy, biosimilars of Denosumab, to treat bone diseases in adults & ...

Biocon Biologics announced that the Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisations in the United Kingdom (UK) for Vevzuo and Evfraxy, biosimilars of ...

Shrinking height in older adults is due to ageing. It could mean serious spinal fractures caused by bone loss over time.

Clinical studies have demonstrated that both biosimilars are comparable in safety and efficacy to the reference product, the ...